Concentrations of tumor-associated trypsin inhibitor and C-reactive protein in serum in acute pelvic inflammatory disease.
Open Access
- 1 May 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 35 (5) , 869-871
- https://doi.org/10.1093/clinchem/35.5.869
Abstract
We measured tumor-associated trypsin inhibitor (TATI) and C-reactive protein (CRP) in serum of 29 patients with proven pelvic inflammatory disease (PID). TATI values were increased in seven (24%), paralleling increases in CRP. TATI was increased by about 3.5-fold in seven of eight patients with CRP concentrations greater than 90 mg/L, but in none of 21 patients with CRP concentrations less than 90 mg/L. TATI concentration and severity of PID as determined by laparoscopy or endometrial biopsy were not correlated. These results suggest that, in severe infections, regulation of TATI synthesis resembles that of acute-phase proteins.This publication has 2 references indexed in Scilit:
- Microbial Causes of Proven Pelvic Inflammatory Disease and Efficacy of Clindamycin and TobramycinAnnals of Internal Medicine, 1986
- Pancreatic secretory trypsin inhibitor-like immunoreactivity in pancreatectomized patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1985